A blood test that speeds up the diagnosis of heart attacks could free up doctors’ time and save the NHS millions of pounds a year. More than two-thirds of people who go to A&E with chest pain have not had a heart attack.
At present, all of these patients undergo a blood test when they arrive at A&E and again three hours later which is designed to detect damage to the heart muscle.
The test works by analyzing biomarkers, including cardiac troponin. Those with undetectable levels of cardiac troponin are classified as low risk and are discharged from hospital.
However, up to 85 per cent of patients fall into an intermediate risk group, requiring an overnight stay and further blood tests.
Scientists at Kings College London have devised a new test that detects damage to the heart quicker
Compared to the troponin test, the new test doubled the number of patients found not to be having a heart attack.
Experts calculated that just one UK hospital – St Thomas’ in London, which carries out 7,800 heart attack tests each year – could save £800,000 a year by reducing admissions and freeing up beds.
Across the entire NHS, the figure will be much higher, although the charity could not give an estimate of how much in total could be saved.
Levels of cMyC in the blood increase more rapidly after a heart attack, and to a higher extent, than troponin.
The new test – which could be rolled out across the NHS in the next five years – can therefore lead to a much more rapid diagnosis.
It enables those not suffering a heart attack to be sent home sooner, and may also pick up heart attacks not detected by the current test.
Experts calculated that just one UK hospital – St Thomas’ in London, which carries out 7,800 heart attack tests each year – could save £800,000 a year by reducing admissions and freeing up beds.
Across the entire NHS, the figure will be much higher, although the charity could not give an estimate of how much in total could be saved. 
Dr Tom Kaier, one of the lead researchers, said the new test could quickly “reassure” thousands of patients that they are fine and would help “free up valuable hospital beds in A&E departments and wards across the country.”
Professor Sir Nilesh Samani of the British Heart Foundation said more research was needed before the current test could be replaced.
But he added: “Big heart attacks are often easy to diagnose with an ECG but smaller heart attacks, which are more common and also life-threatening, are more challenging.
85 per cent of people going to A&E with chest pains have to stay overnight for observation and tests. Smaller heart attacks, which are more common and also life-threatening, are more challenging
A blood test that speeds up the diagnosis of heart attacks could free up doctors’ time and save the NHS millions of pounds a year. More than two-thirds of people who go to A&E with chest pain have not had a heart attack.
At present, all of these patients undergo a blood test when they arrive at A&E and again three hours later which is designed to detect damage to the heart muscle.
The test works by analyzing biomarkers, including cardiac troponin. Those with undetectable levels of cardiac troponin are classified as low risk and are discharged from hospital.
However, up to 85 per cent of patients fall into an intermediate risk group, requiring an overnight stay and further blood tests.
Scientists at Kings College London have devised a new test that detects damage to the heart quicker
Compared to the troponin test, the new test doubled the number of patients found not to be having a heart attack.
Experts calculated that just one UK hospital – St Thomas’ in London, which carries out 7,800 heart attack tests each year – could save £800,000 a year by reducing admissions and freeing up beds.
Across the entire NHS, the figure will be much higher, although the charity could not give an estimate of how much in total could be saved.
Levels of cMyC in the blood increase more rapidly after a heart attack, and to a higher extent, than troponin.
The new test – which could be rolled out across the NHS in the next five years – can therefore lead to a much more rapid diagnosis.
It enables those not suffering a heart attack to be sent home sooner, and may also pick up heart attacks not detected by the current test.
Experts calculated that just one UK hospital – St Thomas’ in London, which carries out 7,800 heart attack tests each year – could save £800,000 a year by reducing admissions and freeing up beds.
Across the entire NHS, the figure will be much higher, although the charity could not give an estimate of how much in total could be saved.
Dr Tom Kaier, one of the lead researchers, said the new test could quickly “reassure” thousands of patients that they are fine and would help “free up valuable hospital beds in A&E departments and wards across the country.”
Professor Sir Nilesh Samani of the British Heart Foundation said more research was needed before the current test could be replaced.
But he added: “Big heart attacks are often easy to diagnose with an ECG but smaller heart attacks, which are more common and also life-threatening, are more challenging.
85 per cent of people going to A&E with chest pains have to stay overnight for observation and tests. Smaller heart attacks, which are more common and also life-threatening, are more challenging
A blood test that speeds up the diagnosis of heart attacks could free up doctors’ time and save the NHS millions of pounds a year. More than two-thirds of people who go to A&E with chest pain have not had a heart attack.
At present, all of these patients undergo a blood test when they arrive at A&E and again three hours later which is designed to detect damage to the heart muscle.
The test works by analyzing biomarkers, including cardiac troponin. Those with undetectable levels of cardiac troponin are classified as low risk and are discharged from hospital.
However, up to 85 per cent of patients fall into an intermediate risk group, requiring an overnight stay and further blood tests.
Scientists at Kings College London have devised a new test that detects damage to the heart quicker
Compared to the troponin test, the new test doubled the number of patients found not to be having a heart attack.
Experts calculated that just one UK hospital – St Thomas’ in London, which carries out 7,800 heart attack tests each year – could save £800,000 a year by reducing admissions and freeing up beds.
Across the entire NHS, the figure will be much higher, although the charity could not give an estimate of how much in total could be saved.
Levels of cMyC in the blood increase more rapidly after a heart attack, and to a higher extent, than troponin.
The new test – which could be rolled out across the NHS in the next five years – can therefore lead to a much more rapid diagnosis.
It enables those not suffering a heart attack to be sent home sooner, and may also pick up heart attacks not detected by the current test.
Experts calculated that just one UK hospital – St Thomas’ in London, which carries out 7,800 heart attack tests each year – could save £800,000 a year by reducing admissions and freeing up beds.
Across the entire NHS, the figure will be much higher, although the charity could not give an estimate of how much in total could be saved.
Dr Tom Kaier, one of the lead researchers, said the new test could quickly “reassure” thousands of patients that they are fine and would help “free up valuable hospital beds in A&E departments and wards across the country.”
Professor Sir Nilesh Samani of the British Heart Foundation said more research was needed before the current test could be replaced.
But he added: “Big heart attacks are often easy to diagnose with an ECG but smaller heart attacks, which are more common and also life-threatening, are more challenging.
85 per cent of people going to A&E with chest pains have to stay overnight for observation and tests. Smaller heart attacks, which are more common and also life-threatening, are more challenging
A blood test that speeds up the diagnosis of heart attacks could free up doctors’ time and save the NHS millions of pounds a year. More than two-thirds of people who go to A&E with chest pain have not had a heart attack.
At present, all of these patients undergo a blood test when they arrive at A&E and again three hours later which is designed to detect damage to the heart muscle.
The test works by analyzing biomarkers, including cardiac troponin. Those with undetectable levels of cardiac troponin are classified as low risk and are discharged from hospital.
However, up to 85 per cent of patients fall into an intermediate risk group, requiring an overnight stay and further blood tests.
Scientists at Kings College London have devised a new test that detects damage to the heart quicker
Compared to the troponin test, the new test doubled the number of patients found not to be having a heart attack.
Experts calculated that just one UK hospital – St Thomas’ in London, which carries out 7,800 heart attack tests each year – could save £800,000 a year by reducing admissions and freeing up beds.
Across the entire NHS, the figure will be much higher, although the charity could not give an estimate of how much in total could be saved.
Levels of cMyC in the blood increase more rapidly after a heart attack, and to a higher extent, than troponin.
The new test – which could be rolled out across the NHS in the next five years – can therefore lead to a much more rapid diagnosis.
It enables those not suffering a heart attack to be sent home sooner, and may also pick up heart attacks not detected by the current test.
Experts calculated that just one UK hospital – St Thomas’ in London, which carries out 7,800 heart attack tests each year – could save £800,000 a year by reducing admissions and freeing up beds.
Across the entire NHS, the figure will be much higher, although the charity could not give an estimate of how much in total could be saved.
Dr Tom Kaier, one of the lead researchers, said the new test could quickly “reassure” thousands of patients that they are fine and would help “free up valuable hospital beds in A&E departments and wards across the country.”
Professor Sir Nilesh Samani of the British Heart Foundation said more research was needed before the current test could be replaced.
But he added: “Big heart attacks are often easy to diagnose with an ECG but smaller heart attacks, which are more common and also life-threatening, are more challenging.
85 per cent of people going to A&E with chest pains have to stay overnight for observation and tests. Smaller heart attacks, which are more common and also life-threatening, are more challenging
A blood test that speeds up the diagnosis of heart attacks could free up doctors’ time and save the NHS millions of pounds a year. More than two-thirds of people who go to A&E with chest pain have not had a heart attack.
At present, all of these patients undergo a blood test when they arrive at A&E and again three hours later which is designed to detect damage to the heart muscle.
The test works by analyzing biomarkers, including cardiac troponin. Those with undetectable levels of cardiac troponin are classified as low risk and are discharged from hospital.
However, up to 85 per cent of patients fall into an intermediate risk group, requiring an overnight stay and further blood tests.
Scientists at Kings College London have devised a new test that detects damage to the heart quicker
Compared to the troponin test, the new test doubled the number of patients found not to be having a heart attack.
Experts calculated that just one UK hospital – St Thomas’ in London, which carries out 7,800 heart attack tests each year – could save £800,000 a year by reducing admissions and freeing up beds.
Across the entire NHS, the figure will be much higher, although the charity could not give an estimate of how much in total could be saved.
Levels of cMyC in the blood increase more rapidly after a heart attack, and to a higher extent, than troponin.
The new test – which could be rolled out across the NHS in the next five years – can therefore lead to a much more rapid diagnosis.
It enables those not suffering a heart attack to be sent home sooner, and may also pick up heart attacks not detected by the current test.
Experts calculated that just one UK hospital – St Thomas’ in London, which carries out 7,800 heart attack tests each year – could save £800,000 a year by reducing admissions and freeing up beds.
Across the entire NHS, the figure will be much higher, although the charity could not give an estimate of how much in total could be saved.
Dr Tom Kaier, one of the lead researchers, said the new test could quickly “reassure” thousands of patients that they are fine and would help “free up valuable hospital beds in A&E departments and wards across the country.”
Professor Sir Nilesh Samani of the British Heart Foundation said more research was needed before the current test could be replaced.
But he added: “Big heart attacks are often easy to diagnose with an ECG but smaller heart attacks, which are more common and also life-threatening, are more challenging.
85 per cent of people going to A&E with chest pains have to stay overnight for observation and tests. Smaller heart attacks, which are more common and also life-threatening, are more challenging
A blood test that speeds up the diagnosis of heart attacks could free up doctors’ time and save the NHS millions of pounds a year. More than two-thirds of people who go to A&E with chest pain have not had a heart attack.
At present, all of these patients undergo a blood test when they arrive at A&E and again three hours later which is designed to detect damage to the heart muscle.
The test works by analyzing biomarkers, including cardiac troponin. Those with undetectable levels of cardiac troponin are classified as low risk and are discharged from hospital.
However, up to 85 per cent of patients fall into an intermediate risk group, requiring an overnight stay and further blood tests.
Scientists at Kings College London have devised a new test that detects damage to the heart quicker
Compared to the troponin test, the new test doubled the number of patients found not to be having a heart attack.
Experts calculated that just one UK hospital – St Thomas’ in London, which carries out 7,800 heart attack tests each year – could save £800,000 a year by reducing admissions and freeing up beds.
Across the entire NHS, the figure will be much higher, although the charity could not give an estimate of how much in total could be saved.
Levels of cMyC in the blood increase more rapidly after a heart attack, and to a higher extent, than troponin.
The new test – which could be rolled out across the NHS in the next five years – can therefore lead to a much more rapid diagnosis.
It enables those not suffering a heart attack to be sent home sooner, and may also pick up heart attacks not detected by the current test.
Experts calculated that just one UK hospital – St Thomas’ in London, which carries out 7,800 heart attack tests each year – could save £800,000 a year by reducing admissions and freeing up beds.
Across the entire NHS, the figure will be much higher, although the charity could not give an estimate of how much in total could be saved.
Dr Tom Kaier, one of the lead researchers, said the new test could quickly “reassure” thousands of patients that they are fine and would help “free up valuable hospital beds in A&E departments and wards across the country.”
Professor Sir Nilesh Samani of the British Heart Foundation said more research was needed before the current test could be replaced.
But he added: “Big heart attacks are often easy to diagnose with an ECG but smaller heart attacks, which are more common and also life-threatening, are more challenging.
85 per cent of people going to A&E with chest pains have to stay overnight for observation and tests. Smaller heart attacks, which are more common and also life-threatening, are more challenging
A blood test that speeds up the diagnosis of heart attacks could free up doctors’ time and save the NHS millions of pounds a year. More than two-thirds of people who go to A&E with chest pain have not had a heart attack.
At present, all of these patients undergo a blood test when they arrive at A&E and again three hours later which is designed to detect damage to the heart muscle.
The test works by analyzing biomarkers, including cardiac troponin. Those with undetectable levels of cardiac troponin are classified as low risk and are discharged from hospital.
However, up to 85 per cent of patients fall into an intermediate risk group, requiring an overnight stay and further blood tests.
Scientists at Kings College London have devised a new test that detects damage to the heart quicker
Compared to the troponin test, the new test doubled the number of patients found not to be having a heart attack.
Experts calculated that just one UK hospital – St Thomas’ in London, which carries out 7,800 heart attack tests each year – could save £800,000 a year by reducing admissions and freeing up beds.
Across the entire NHS, the figure will be much higher, although the charity could not give an estimate of how much in total could be saved.
Levels of cMyC in the blood increase more rapidly after a heart attack, and to a higher extent, than troponin.
The new test – which could be rolled out across the NHS in the next five years – can therefore lead to a much more rapid diagnosis.
It enables those not suffering a heart attack to be sent home sooner, and may also pick up heart attacks not detected by the current test.
Experts calculated that just one UK hospital – St Thomas’ in London, which carries out 7,800 heart attack tests each year – could save £800,000 a year by reducing admissions and freeing up beds.
Across the entire NHS, the figure will be much higher, although the charity could not give an estimate of how much in total could be saved.
Dr Tom Kaier, one of the lead researchers, said the new test could quickly “reassure” thousands of patients that they are fine and would help “free up valuable hospital beds in A&E departments and wards across the country.”
Professor Sir Nilesh Samani of the British Heart Foundation said more research was needed before the current test could be replaced.
But he added: “Big heart attacks are often easy to diagnose with an ECG but smaller heart attacks, which are more common and also life-threatening, are more challenging.
85 per cent of people going to A&E with chest pains have to stay overnight for observation and tests. Smaller heart attacks, which are more common and also life-threatening, are more challenging
A blood test that speeds up the diagnosis of heart attacks could free up doctors’ time and save the NHS millions of pounds a year. More than two-thirds of people who go to A&E with chest pain have not had a heart attack.
At present, all of these patients undergo a blood test when they arrive at A&E and again three hours later which is designed to detect damage to the heart muscle.
The test works by analyzing biomarkers, including cardiac troponin. Those with undetectable levels of cardiac troponin are classified as low risk and are discharged from hospital.
However, up to 85 per cent of patients fall into an intermediate risk group, requiring an overnight stay and further blood tests.
Scientists at Kings College London have devised a new test that detects damage to the heart quicker
Compared to the troponin test, the new test doubled the number of patients found not to be having a heart attack.
Experts calculated that just one UK hospital – St Thomas’ in London, which carries out 7,800 heart attack tests each year – could save £800,000 a year by reducing admissions and freeing up beds.
Across the entire NHS, the figure will be much higher, although the charity could not give an estimate of how much in total could be saved.
Levels of cMyC in the blood increase more rapidly after a heart attack, and to a higher extent, than troponin.
The new test – which could be rolled out across the NHS in the next five years – can therefore lead to a much more rapid diagnosis.
It enables those not suffering a heart attack to be sent home sooner, and may also pick up heart attacks not detected by the current test.
Experts calculated that just one UK hospital – St Thomas’ in London, which carries out 7,800 heart attack tests each year – could save £800,000 a year by reducing admissions and freeing up beds.
Across the entire NHS, the figure will be much higher, although the charity could not give an estimate of how much in total could be saved.
Dr Tom Kaier, one of the lead researchers, said the new test could quickly “reassure” thousands of patients that they are fine and would help “free up valuable hospital beds in A&E departments and wards across the country.”
Professor Sir Nilesh Samani of the British Heart Foundation said more research was needed before the current test could be replaced.
But he added: “Big heart attacks are often easy to diagnose with an ECG but smaller heart attacks, which are more common and also life-threatening, are more challenging.
85 per cent of people going to A&E with chest pains have to stay overnight for observation and tests. Smaller heart attacks, which are more common and also life-threatening, are more challenging
Related posts:
World Blood Donor Day : Nigerians urged to donate blood often
World Blood Donor Day: “Safe blood for all”
Seadogs donate blood, creates awareness for improved blood donation
Risk of mass starvation rapidly rising in Yemen, Somalia, two others – UNHCR
Cancer Pen Could Detect Tumors During Surgery in Seconds
Can you have a heart attack and not know?
More Americans at risk for heart attack and stroke – Research
MMM founder, Sergei Mavrodi, dies of heart attack at 62
